About Digestive Healthcare of Georgia
Clinical Trials at Digestive Healthcare of Georgia
During the past decade, Digestive Healthcare of Georgia conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 17 clinical trials were completed, i.e. on
average, 65.4% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 13 clinical trials were completed. i.e. 130%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Digestive Healthcare of Georgia" #1 sponsor was "Gilead Sciences" with 10 trials, followed by "Eli Lilly and Company" with 6 trials
sponsored, "CymaBay Therapeutics, Inc." with 4 trials sponsored, "Pfizer" with 3 trials sponsored and "Bausch Health Americas, Inc."
with 3 trials sponsored. Other sponsors include 11 different institutions and
companies that sponsored additional 19 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Digestive Healthcare of Georgia"
#1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator and "FGK Clinical Research GmbH" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Digestive Healthcare of Georgia
According to Clinical.Site data, the most researched conditions in "Digestive Healthcare of Georgia" are
"Hepatitis C, Chronic" (5 trials), "Chronic Hepatitis C" (4 trials), "Crohn's Disease" (4 trials), "Nonalcoholic Steatohepatitis" (4 trials) and "Ulcerative Colitis" (4 trials). Many other conditions were trialed in "Digestive Healthcare of Georgia" in a lesser frequency.
Clinical Trials Intervention Types at Digestive Healthcare of Georgia
Most popular intervention types in "Digestive Healthcare of Georgia" are "Drug" (38 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (16 trials), "Mirikizumab" (5 trials), "RBV" (4 trials), "SEL" (3 trials) and "SOF" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Digestive Healthcare of Georgia
The vast majority of trials in "Digestive Healthcare of Georgia" are
39 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Digestive Healthcare of Georgia
Currently, there are NaN active trials in "Digestive Healthcare of Georgia".
undefined are not yet recruiting,
7 are recruiting,
8 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 21 completed trials in Digestive Healthcare of Georgia,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Digestive Healthcare of Georgia, 0 "Phase 1"
clinical trials were conducted, 13 "Phase 2" clinical
trials and 26 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".